Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludovit Paulis

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Nature Reviews. Cardiology|June 23, 2010
Novel therapeutic targets for hypertensionLudovit Paulis, Thomas Unger
Journal of Pineal Research|April 19, 2007
Melatonin as a potential antihypertensive treatmentFedor Simko, Ludovit Paulis
Journal of Pineal Research|March 6, 2008
Chronotherapy beyond blood pressure reduction?Fedor Simko, Ludovit Paulis
Journal of Hypertension|August 17, 2012
Hypertensive heart disease: bone marrow as a significant player in pathologic remodelling?Fedor Simko, Ludovit Paulis
International Journal of Cardiology|April 25, 2013
Antifibrotic effect of melatonin--perspective protection in hypertensive heart diseaseFedor Simko, Ludovit Paulis
Hypertension (Dallas, Tex. : 1979)|November 7, 2007
LA419, a novel nitric oxide donor, prevents cardiac remodeling via the endothelial nitric oxide synthase pathway: NO donors as a means of antiremodelingLudovit Paulis, Fedor Simko
Current Pharmaceutical Design|September 10, 2015
N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP): Potential target molecule in research of heart, kidney and brainJaroslav Hrenak, Ludovit Paulis, Fedor Simko
Expert Opinion on Biological Therapy|August 8, 2017
Gene therapy for hypertensionLudovit Paulis, Heinrich Franke, Fedor Simko
International Journal of Molecular Sciences|October 10, 2014
Peripheral and central effects of melatonin on blood pressure regulationOlga Pechanova, Ludovit Paulis, Fedor Simko
Current Hypertension Reports|April 21, 2015
New developments in the pharmacological treatment of hypertension: dead-end or a glimmer at the horizon?Ludovit Paulis, Romana Rajkovicova, Fedor Simko
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Nature Reviews. Cardiology|June 23, 2010
Novel therapeutic targets for hypertensionLudovit Paulis, Thomas Unger
Journal of Pineal Research|April 19, 2007
Melatonin as a potential antihypertensive treatmentFedor Simko, Ludovit Paulis
Journal of Pineal Research|March 6, 2008
Chronotherapy beyond blood pressure reduction?Fedor Simko, Ludovit Paulis
Journal of Hypertension|August 17, 2012
Hypertensive heart disease: bone marrow as a significant player in pathologic remodelling?Fedor Simko, Ludovit Paulis
International Journal of Cardiology|April 25, 2013
Antifibrotic effect of melatonin--perspective protection in hypertensive heart diseaseFedor Simko, Ludovit Paulis
Hypertension (Dallas, Tex. : 1979)|November 7, 2007
LA419, a novel nitric oxide donor, prevents cardiac remodeling via the endothelial nitric oxide synthase pathway: NO donors as a means of antiremodelingLudovit Paulis, Fedor Simko
Current Pharmaceutical Design|September 10, 2015
N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP): Potential target molecule in research of heart, kidney and brainJaroslav Hrenak, Ludovit Paulis, Fedor Simko
Expert Opinion on Biological Therapy|August 8, 2017
Gene therapy for hypertensionLudovit Paulis, Heinrich Franke, Fedor Simko
International Journal of Molecular Sciences|October 10, 2014
Peripheral and central effects of melatonin on blood pressure regulationOlga Pechanova, Ludovit Paulis, Fedor Simko
Current Hypertension Reports|April 21, 2015
New developments in the pharmacological treatment of hypertension: dead-end or a glimmer at the horizon?Ludovit Paulis, Romana Rajkovicova, Fedor Simko
Pageof 6